期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Mechanisms of acquired resistance to fibroblast growth factor receptor targeted therapy
1
作者 David K.Lau Laura Jenkins Andrew Weickhardt 《Cancer Drug Resistance》 2019年第3期568-579,共12页
Oncogenic activation of the fibroblast growth factor receptor(FGFR)through mutations and fusions of the FGFR gene occur in a variety of different malignancies such as urothelial carcinoma and cholangiocarcinoma.Inhibi... Oncogenic activation of the fibroblast growth factor receptor(FGFR)through mutations and fusions of the FGFR gene occur in a variety of different malignancies such as urothelial carcinoma and cholangiocarcinoma.Inhibition of the kinase domain of the FGFR with targeted oral FGFR inhibitors has been shown in both preclinical and early phase clinical trials to lead to meaningful reductions in tumour size and larger confirmatory randomized trials are underway.Acquired resistance to FGFR inhibition using a variety of mechanisms that includes,activation of alternate signaling pathways and expansion of tumour clones with gatekeeper mutations in the FGFR gene.This review summarizes the acquired resistance mechanisms to FGFR therapy and therapeutic approaches to circumventing resistance. 展开更多
关键词 Fibroblast growth factor receptor targeted therapy acquired resistance
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部